MIFH
MRNA icon

Migdal Insurance & Financial Holdings’s Moderna MRNA Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,312
Closed -$565K – 641
2021
Q1 		$565K Buy
4,312
+2,676
+164% +$388K 0.01% 307
2020
Q4 		$171K Buy
+1,636
New +$166K ﹤0.01% 335

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Migdal Insurance & Financial Holdings's MRNA Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Moderna (MRNA) in Q2 2021, closing a stake of 4,312 shares — an estimated $565K sold.

Migdal Insurance & Financial Holdings first reported a position in MRNA in Q4 2020 and held it in 2 quarters. The position peaked at $565K in Q1 2021. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 4,312 Moderna shares in Q2 2021, an estimated $565K.
  • Migdal Insurance & Financial Holdings first reported a position in Moderna in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Moderna position peaked at $565K in Q1 2021.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.